 Connection
Kap Sum Foong to Treatment Outcome
This is a "connection" page, showing publications Kap Sum Foong has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.059 |
|
|
|
-
Foong KS, Lee A, Pekez M, Bin W. Imipenem/cilastatin-induced acute eosinophilic pneumonia. BMJ Case Rep. 2016 Mar 04; 2016.
Score: 0.041
-
Gottlieb RL, Clement M, Cook P, Deveikis A, Foong KS, Robinson P, Slim J, Spak CW, Buelens A, Callewaert K, De Meyer S, Mo WL, Verbrugge I, Van Wesenbeeck L, Zhuang Y, Chien JW, Opsomer M, Van Landuyt E. The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19. J Infect. 2024 Oct; 89(4):106241.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|